We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cocoa May Help Suppress Colon Cancer

By LabMedica International staff writers
Posted on 14 Feb 2012
A new study on living lab rats has shown for the first time that eating cocoa can help prevent intestinal disorders associated with oxidative stress, including colon carcinogenesis onset caused by chemical compounds.

The growing interest among the scientists to identify those foods capable of preventing diseases has now branded cocoa as a “superfood.” It has been recognized as an excellent source of phytochemical compounds, which offer potential health benefits.

Led by scientists from the Institute of Food Science and Technology and Nutrition (ICTAN; Madrid, Spain) and published in the December 2011 issue of the Molecular Nutrition & Food Research journal, the new study supports this hypothesis and maintains the claim that cacao consumption helps to prevent intestinal problems associated oxidative stress, such as the onset of chemically induced colon carcinogenesis.

“Being exposed to different poisons in the diet like toxins, mutagens, and procarcinogens, the intestinal mucus is very susceptible to pathologies,” explained Dr. More...
María Ángeles Martín Arribas, lead author of the study and researcher at ICTAN. She added that, “foods like cocoa, which is rich in polyphenols, seems to play an important role in protecting against disease.”

The study on live rats has validated, for the first time, the potential protection effect that flavonoids in cocoa have against colon cancer onset. For eight weeks, the scientists of the study fed the rats with a cocoa-rich (12%) diet and carcinogenesis was induced.

Dr. Martín Arribas reported that, “four weeks after being administered with the chemical compound azoxymethane [AOM], intestinal mucus from premalignant neoplastic lesions appeared. These lesions are called ‘aberrant crypt foci’ and are considered to be good markers of colon cancer pathogenesis.”

The study’s findings revealed that the rats fed a cocoa-rich diet had a considerably reduced number of aberrant crypt foci in the colon induced by the carcinogen. Similarly, this sample saw an improvement in their endogenous antioxidant defenses and a decrease in the markers of oxidative damage induced by the toxic compound in this cell.

The researchers concluded that the protection effect of cocoa can block cell-signaling pathways involved in cell proliferation, and therefore, subsequent neoplasty and tumor formation. Lastly, the animals fed with the cocoa-rich diet showed an increase in apoptosis as a chemoprevention process against the development of the carcinogenesis.

Although more research is required to determine what bioactive compounds in cocoa are responsible for such effects, the authors concluded that a cocoa-rich diet seems capable of reducing induced oxidative stress. It could also have protection properties in the initial stages of colon cancer as it reduces premalignant neoplastic lesion formation.

Cocoa is one of the chief ingredients in chocolate. It is one of the richest foods in phenolic compounds, mainly in flavonoids such as procyanidins, catechins, and epicatechins, which have numerous beneficial biologic activities in the prevention of cardiovascular diseases and cancer (mainly colorectal cancer).

In fact, compared to other foods with high flavonoid content, cocoa has a high level of procyanidins with limited bioavailability. These flavonoids are therefore found in their highest concentrations in the intestine where they neutralize many oxidants.



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Laboratory Software
ArtelWare
New
Blood Glucose Test Strip
AutoSense Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: An innovative deep learning model can accurately predict MSI tumor and immune checkpoint inhibitor responsiveness (Photo courtesy of Jae-Ho Cheong/Yonsei University College of Medicine)

AI Model Accurately Predicts MSI Tumor and Immune Checkpoint Inhibitor Responsiveness

One in three people is expected to develop cancer in their lifetime, and a key factor in patient prognosis is the tumor’s microsatellite status—whether it is stable or shows microsatellite instability-high (MSI-H).... Read more

Pathology

view channel
Image: Virtual staining of label-free tissue in imaging mass spectrometry (Photo courtesy of Ozcan Lab/UCLA)

Deep Learning Advances Imaging Mass Spectrometry with Virtual Histological Detail

Imaging mass spectrometry (IMS) is a powerful technique that can map thousands of molecular species in biological tissues with exceptional chemical specificity. However, IMS is hindered by relatively low... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.